Related Experiment Video
Updated: May 16, 2026

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
Published on: August 2, 2024
The effect of HES (130/0.4) usage as the priming solution on renal function in children undergoing cardiac surgery
Fulya G Akkucuk1, Meral Kanbak, Banu Ayhan
1Department of Anesthesiology and Reanimation, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Insights
Hydroxyethyl starch (HES) did not negatively impact renal function in pediatric cardiac surgery patients. This fluid can be safely used as a priming solution during cardiopulmonary bypass, showing no adverse effects on kidney function.
Area of Science:
- Pediatric Cardiac Surgery
- Nephrology
- Anesthesiology
Background:
- Limited data exists on hydroxyethyl starch (HES) use in pediatric patients.
- Assessing renal function effects of HES versus Ringer's lactate (RL) as a priming solution in pediatric cardiac surgery is crucial.
Purpose of the Study:
- To evaluate the safety and efficacy of hydroxyethyl starch (HES) (130/0.4) as a cardiopulmonary bypass (CPB) priming solution in pediatric patients.
- To compare the effects of HES and Ringer's lactate (RL) on renal function markers in children undergoing cardiac surgery.
Main Methods:
- A prospective, randomized study involving 24 pediatric patients undergoing cardiac surgery.
- Patients received either RL (Group I) or HES (130/0.4) (Group II) as the CPB priming solution.
- Renal function markers including serum creatinine, BUN, β2-microglobulin, cystatin C, and urinary albumin/creatinine ratio were monitored at multiple time points.
Main Results:
- No significant differences were observed between HES and RL groups in cystatin C, β2-microglobulin, FENa, urine albumin/creatinine ratio, creatinine clearance, fluid balance, or urine output.
- While creatinine clearance increased in the RL group, it remained stable in the HES group.
- Urine albumin/creatinine ratio increased post-CPB in the HES group and during CPB in the RL group, with no overall group difference.
Conclusions:
- Hydroxyethyl starch (HES) (130/0.4) can be safely administered as a priming solution in pediatric patients undergoing cardiac surgery.
- HES did not demonstrate negative effects on renal function in this pediatric cohort.
- The study supports the use of HES as an alternative priming solution in pediatric cardiac surgery.
Background:
Experience with hydroxyethyl starch (HES) in children is limited. This study was conducted to observe the effects of HES or Ringer's lactate (RL) usage as the priming solution on renal functions in children undergoing cardiac surgery.
Methods:
After ethical committee approval and parent informed consent, 24 patients were included in this prospective, randomized study. During cardiopulmonary bypass (CPB), Group I received RL and Group II received HES (130/0.4) as priming solution. Serum creatinine, blood urea nitrogen (BUN), β2-microglobulin, cystatin C, and urinary albumin and creatinine, serum, and urine electrolytes were analyzed after the induction (T1), before CPB (T2), during CPB (T3), after CPB (T4), at the end of the operation (T5), on 24th hour (T6), and on 48th hour postoperatively (T7). Fractional sodium excretion (FENa), urinary albumin/creatinine ratio, and creatinine clearance were calculated. Drainage, urine output, inotropes, diuretics, and blood requirements were recorded.
Results:
In both the groups, β2-microglobulin was decreased during CPB and cystatin C was decreased at T3,T4, and T5 periods (p < 0.05) and the levels remained within the normal range. Creatinine clearance did not differ in the HES group, but increased in the RL group (p < 0.05). Urine albumin/creatinine ratio was increased (p < 0.05) after CPB in the HES group, and it increased at T3, T4, and T5 in the RL group (p < 0.05). There were no differences in cystatin C, β2-microglobulin, FENa, urine albumin/creatinine ratio, creatinine clearance, total fluid amount, urine output, drainage, and inotropic and diuretic requirements between the groups.
Conclusion:
We conclude that usage of HES (130/0.4) did not have negative effects on renal function, and it can be used as a priming solution in pediatric patients undergoing cardiac surgery.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Heart Failure Drugs: Diuretics
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations